Address
250 Washington St., 2nd Floor, Boston, MA 02108
- This page, Drug Formulary Commission meeting, is offered by
- Drug Control Program
- Bureau of Health Professions Licensure
- Department of Public Health
Public Meeting Notice
Public Meeting Notice Drug Formulary Commission meeting
Overview of Drug Formulary Commission meeting
In the Henry I. Bowditch Public Health Council Room, on the 2nd floor.
Monographs
- Proposed Monograph (11-3-15)
- Approved Monograph (11-16-15)
- Sample Monograph and Studies:
- Oxycontin Monograph
- Abuse-Deterrent Formulations, an Evolving Technology Against the Abuse and Misuse of Opioid Analgesics (DOC)
- Opioids and the Treatment of Chronic Pain: Controversies, Current Status, and Future Directions (DOC)
- An Analysis of the Number of Multiple Prescribers for Opioids Utilizing Data from the California Prescription Monitoring (DOC)
- Reductions in Reported Deaths Following the Introduction of Extended-Release Oxycodone (Oxycontin) with an Abuse-Deterrent Formulation (DOC)
Meeting Minutes
Open DOC file, 64.5 KB,
Approved Minutes of November 5, 2015 Meeting
(English, DOC 64.5 KB)
Agenda
Agenda
- ROUTINE ITEMS:
- Welcome and Opening Remarks
- Approval of the Minutes (Vote)
- DISCUSSION OF EVALUATION CRITERIA:
- Therapeutically Equivalent Substitution Criteria (Vote)
- Inclusion of Drug Products with FDA Approved Labeling (Vote)
- UPDATE ON DATA REQUESTS:
- Presentation of Data
Additional Resources for Drug Formulary Commission meeting
Open PPTX file, 781.37 KB,
Meeting Presentation (Power Point)
(English, PPTX 781.37 KB)
Open DOCX file, 757.07 KB,
Meeting Presentation (Power Point)
(English, DOCX 757.07 KB)